Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Prolonged Fluconazole Prophylaxis Is Not Required In Patients With Acute Leukemias Or Myelodysplastic/Myeloproliferative Disorders After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT): A Pair-Matched Analysis

Eolia Brissot, MD, Xavier Cahu, MD, Thierry Guillaume, MD, Jacques Delaunay, MD, Sameh Ayari, Cristina Precupanu, MD PhD, Pierre Peterlin, Jean-Luc Harousseau, MD, Noel Milpied, MD, PhD, Philippe Moreau, MD, Mohamad Mohty, MD, PhD, Patrice Chevallier, MD, PhD

Blood (2013) 122 (21): 4543.

https://doi.org/10.1182/blood.V122.21.4543.4543

Published: 2013

Journal Articles

Prognostic Impact of Hematopoietic Recovery After Fludarabine, IV Busulfan and Antithymocyte Globulins (FB2 regimen) Reduced-Intensity Conditioning Regimen (RIC) Allogeneic Stem Cell Transplantation (allo-SCT)

Blood (2012) 120 (21): 4483.

https://doi.org/10.1182/blood.V120.21.4483.4483

Published: 2012

Journal Articles

Comparison of PBSC Vs Cord Blood (CB) As Stem Cells Source for Reduced-Intensity Conditioning Regimen (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Haematological Diseases: A Single Centre Analysis.

Blood (2012) 120 (21): 3108.

https://doi.org/10.1182/blood.V120.21.3108.3108

Published: 2012

Journal Articles

5-Azacytidine (AZA) Compared to Intensive Chemotherapy in Elderly Acute Myeloid Leukemia (AML) Patients: Results of a Retrospective Single Centre Matched Analysis,

Elsa Lestang, Sameh Ayari, Patrice Chevallier, MD, Thierry Guillaume, Fanny Rialland, M.D., Nicolas Blin, MD, Nadia Fayad, Aline Clavert, Virginie Roland, Thomas Gastinne, Beatrice Mahe, Viviane Dubruille, Steven Le Gouill, MD, PhD, Philippe Moreau, MD, Mohamad Mohty, Jacques Delaunay

Blood (2011) 118 (21): 3620.

https://doi.org/10.1182/blood.V118.21.3620.3620

Published: 2011

Journal Articles

A Scoring System Predictive of Extensive Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Stem Cell Transplantation (allo-SCT)

Eolia Brissot, Yohann Foucher, Florent Malard, Zinaida Peric, Aline Clavert, Patrice Chevallier, MD, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Jean-Luc Harousseau, MD, Philippe Moreau, MD, Marianne Coste-Burel, Berthe-Marie Imbert-Marcille, Marc Gregoire, Cécile Braudeau, Régis Josien, Béatrice Gaugler, Mohamad Mohty

Blood (2011) 118 (21): 1980.

https://doi.org/10.1182/blood.V118.21.1980.1980

Published: 2011

Journal Articles

Long-Term Complications (LTC) and Quality of Life (QOL) After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT),

Aline Clavert, MD, Peric Zina, MD, Xavier Cahu, MD, Patrice Chevallier, MD, Eolia Brissot, Florent Malard, Thierry Guillaume, Jacques Delaunay, MD, Sameh Ayari, Viviane Dubruille, Beatrice Mahe, Nicolas Blin, MD, Thomas Gastinne, Virginie Roland, Steven Le Gouill, MD, PhD, Jean-Luc Harousseau, Philippe Moreau, MD, Noel Milpied, MD, Mohamad Mohty

Blood (2011) 118 (21): 4100.

https://doi.org/10.1182/blood.V118.21.4100.4100

Published: 2011

Journal Articles

Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Unrelated Umbilical Cord Blood Transplantation (UCBT)

Blood (2010) 116 (21): 2334.

https://doi.org/10.1182/blood.V116.21.2334.2334

Published: 2010

Journal Articles

Fludarabine, Low Dose Busulfan and Antithymocyte Globulin (ATG) Compared to Fludarabine and Low Dose Total Body Irradiation (TBI) for Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) In Patients with Lymphoid Malignancies.

Florent Malard, Eolia Brissot, Patrice Chevallier, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Beatrice Mahe, Viviane Dubruille, Thomas Gastinne, Nicolas Blin, Beatrice Saulquin, jean Luc Harousseau, Philippe Moreau, Noel Milpied, MD, Steven Le Gouill, Mohamad Mohty

Blood (2010) 116 (21): 3472.

https://doi.org/10.1182/blood.V116.21.3472.3472

Published: 2010

Journal Articles

Autologous Stem Cell Transplantation In Mantle Cell Lymphoma: Total Body Irradiation (TBI) Plus Cyclophosphamide (or Melphalan) Is Not Superior to BEAM, A Single Institution Experience

Pierre Peterlin, Christophe Leux, Thomas Gastinne, Beatrice Mahe, Viviane Dubruille, Jacques Delaunay, Patrice Chevallier, Thierry Guillaume, Nicolas Blin, Sameh Ayari, irginie Roland, V, Mohamad Mohty, Noel Milpied, MD, Jean-Luc Harousseau, Philippe Moreau, Steven Le Gouill

Blood (2010) 116 (21): 3563.

https://doi.org/10.1182/blood.V116.21.3563.3563

Published: 2010

Journal Articles

Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2010) 116 (21): 1259.

https://doi.org/10.1182/blood.V116.21.1259.1259

Published: 2010

Journal Articles

Immunomodulation by Lymphodepletion and Donor Lymphocyte Infusion to Treat Post Allogeneic Transplantation Relapse

Thierry Guillaume, Béatrice Gaugler, Patrice Chevallier, Sameh Ayari, Jacques Delaunay, Philippe Moreau, MD, Mohamad Mohty, MD, PhD

Blood (2010) 116 (21): 2084.

https://doi.org/10.1182/blood.V116.21.2084.2084

Published: 2010

Journal Articles

Fludarabine, Low Dose Busulfan and Antithymocyte Globulin for Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT).

F. Malard, Eolia Brissot, Patrice Chevallier, MD, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Viviane Dubruille, Steven Le Gouill, MD, PhD, Beatrice Mahe, Thomas Gastinne, Nicolas Blin, Beatrice Saulquin, Jean-Luc Harousseau, Philippe Moreau, MD, Noel-Jean Milpied, MD, Mohamad Mohty, MD, PhD

Blood (2009) 114 (22): 3341.

https://doi.org/10.1182/blood.V114.22.3341.3341

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Secondary Acute Myeloid Leukemia (AML) Following Breast Carcinoma.

Sameh Ayari, Mohamad Mohty, MD, PhD, Karin Bilger, MD, Gaelle Guillerm, Denis Guyotat, MD, PhD, Mauricette Michallet, MD, PhD, Norbert Ifrah, MD, Patrice Chevallier, MD

Blood (2009) 114 (22): 3305.

https://doi.org/10.1182/blood.V114.22.3305.3305

Published: 2009

Journal Articles

Escalated lymphodepletion Followed by Donor Lymphocyte Infusion (DLI) can Induce a Graft-Versus-Host Response without Overwhelming Toxicity.

Thierry Guillaume, Patrice Chevallier, Sameh Ayari, Jacques Delaunay, Francoise Mechinaud, Philippe Moreau, Mohamad Mohty

Blood (2009) 114 (22): 3033.

https://doi.org/10.1182/blood.V114.22.3033.3033

Published: 2009

Journal Articles

Infectious Complications After Unrelated Umbilical Cord Blood Transplantation (UCBT) in Adult Patients with Hematological Malignancies.

Xavier Cahu, Fanny Rialland, Cyrille Touzeau, Patrice Chevallier, MD, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Viviane Dubruille, Steven Le Gouill, MD, PhD, Beatrice Mahe, Thomas Gastinne, Nicolas Blin, Beatrice Saulquin, Jean-Luc Harousseau, Philippe Moreau, MD, Francoise Mechinaud, Mohamad Mohty, MD, PhD

Blood (2009) 114 (22): 1142.

https://doi.org/10.1182/blood.V114.22.1142.1142

Published: 2009

Journal Articles

5-Azacytidine (5-AZA) Salvage Therapy for Very High Risk Acute Myeloid Leukemia (AML): Response After 3 Cycles Is the Major Determinant for Outcome.

Sameh Ayari, Patrice Chevallier, Thierry Guillaume, Eolia Brissot, Steven Le Gouill, MD, PhD, Mohamad Mohty, MD, PhD, Nicolas Blin, Thomas Gastinne, Philippe Moreau, Jean Luc Harousseau, Jacques Delaunay

Blood (2009) 114 (22): 2044.

https://doi.org/10.1182/blood.V114.22.2044.2044

Published: 2009

Journal Articles

Features of Herpesviruses (CMV, EBV, HHV6) Infections and Immune Reconstitution after Allogeneic Stem Cell Transplantation (allo-SCT) Using Alternative Donors: Comparison Between Matched Unrelated Donors (MUD) and Cord Blood (CB) as Stem Cell Source.

Patrice Chevallier, Thierry Guillaume, Lucie Planche, Imen Hebia-Fellah, Celine Bressollette- Bodin, Fanny Rialland, Marianne Coste-Burel, Sameh Ayari, Jacques Delaunay, MD, Valerie Horvais, Jean-Luc Harousseau, Mohamad Mohty, MD, PhD, Berthe-Marie Imbert-Marcille

Blood (2008) 112 (11): 1148.

https://doi.org/10.1182/blood.V112.11.1148.1148

Published: 2008

Journal Articles

Impact of Cyclosporine a (CsA) Concentration on the Incidence of Severe Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT).

Florent Mallard, Eolia Brissot, Patrice Chevallier, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Viviane Dubruille, Steven Legouill, Beatrice Mahe, Thomas Gastinne, Nicolas Blin, Beatrice Saulquin, Philippe Moreau, Jean-Luc Harousseau, Mohamad Mohty

Blood (2008) 112 (11): 1150.

https://doi.org/10.1182/blood.V112.11.1150.1150

Published: 2008

Journal Articles

Prior Treatment with Chemotherapy Associated to Gemtuzumab Ozogamicin (GO) Does Not Increase the Risk of Veno-Occlusive Disease (VOD) after Allogeneic Stem Cell Transplantation (all-SCT).

Patrice Chevallier, Thomas Prebet, MD, Pascal Turlure, Mathilde Hunault, Stephane Vigouroux, Catherine Faucher, Thierry Guillaume, Francoise Mechinaud, Sameh Ayari, Jacques Delaunay, MD, Noel-Jean Milpied, PhD, Jean-Luc Harousseau, Norbert Ifrah, MD, Didier Blaise, Norbert Vey, MD, Mohamad Mohty, MD, PhD

Blood (2008) 112 (11): 1121.

https://doi.org/10.1182/blood.V112.11.1121.1121

Published: 2008

Journal Articles

Donor Lymphocyte Infusions (DLI) for the Treatment of Disease Relapse in Hematological Malignancies Following Allogeneic Transplantation: Similar Efficacy Following RIC or Myeloablative Regimen

Thierry Guillaume, Patrice Chevallier, Sameh Ayari, Jacques Delaunay, Laurence Lode, Francoise Mechinaud, Hervé Avet-Loiseau, Philippe Moreau, Jean Luc Harousseau, Mohamad Mohty

Blood (2008) 112 (11): 2915.

https://doi.org/10.1182/blood.V112.11.2915.2915

Published: 2008

NARROW

Prolonged Fluconazole Prophylaxis Is Not Required In Patients With Acute Leukemias Or Myelodysplastic/Myeloproliferative Disorders After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT): A Pair-Matched Analysis

Prognostic Impact of Hematopoietic Recovery After Fludarabine, IV Busulfan and Antithymocyte Globulins (FB2 regimen) Reduced-Intensity Conditioning Regimen (RIC) Allogeneic Stem Cell Transplantation (allo-SCT)

Comparison of PBSC Vs Cord Blood (CB) As Stem Cells Source for Reduced-Intensity Conditioning Regimen (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Haematological Diseases: A Single Centre Analysis.

5-Azacytidine (AZA) Compared to Intensive Chemotherapy in Elderly Acute Myeloid Leukemia (AML) Patients: Results of a Retrospective Single Centre Matched Analysis,

A Scoring System Predictive of Extensive Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Stem Cell Transplantation (allo-SCT)

Long-Term Complications (LTC) and Quality of Life (QOL) After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT),

Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Unrelated Umbilical Cord Blood Transplantation (UCBT)

Fludarabine, Low Dose Busulfan and Antithymocyte Globulin (ATG) Compared to Fludarabine and Low Dose Total Body Irradiation (TBI) for Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) In Patients with Lymphoid Malignancies.

Autologous Stem Cell Transplantation In Mantle Cell Lymphoma: Total Body Irradiation (TBI) Plus Cyclophosphamide (or Melphalan) Is Not Superior to BEAM, A Single Institution Experience

Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation

Immunomodulation by Lymphodepletion and Donor Lymphocyte Infusion to Treat Post Allogeneic Transplantation Relapse

Fludarabine, Low Dose Busulfan and Antithymocyte Globulin for Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT).

Allogeneic Stem Cell Transplantation (allo-SCT) for Secondary Acute Myeloid Leukemia (AML) Following Breast Carcinoma.

Escalated lymphodepletion Followed by Donor Lymphocyte Infusion (DLI) can Induce a Graft-Versus-Host Response without Overwhelming Toxicity.

Infectious Complications After Unrelated Umbilical Cord Blood Transplantation (UCBT) in Adult Patients with Hematological Malignancies.

5-Azacytidine (5-AZA) Salvage Therapy for Very High Risk Acute Myeloid Leukemia (AML): Response After 3 Cycles Is the Major Determinant for Outcome.

Features of Herpesviruses (CMV, EBV, HHV6) Infections and Immune Reconstitution after Allogeneic Stem Cell Transplantation (allo-SCT) Using Alternative Donors: Comparison Between Matched Unrelated Donors (MUD) and Cord Blood (CB) as Stem Cell Source.

Impact of Cyclosporine a (CsA) Concentration on the Incidence of Severe Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT).

Prior Treatment with Chemotherapy Associated to Gemtuzumab Ozogamicin (GO) Does Not Increase the Risk of Veno-Occlusive Disease (VOD) after Allogeneic Stem Cell Transplantation (all-SCT).

Donor Lymphocyte Infusions (DLI) for the Treatment of Disease Relapse in Hematological Malignancies Following Allogeneic Transplantation: Similar Efficacy Following RIC or Myeloablative Regimen

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only